NCT01317940 Nutrition and Body Composition in Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT01182350 Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Status TERMINATED Phase PHASE2
NCT01158651 Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas Status COMPLETED Phase PHASE2
NCT01089426 Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury Status COMPLETED Phase NA
NCT01088607 Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis Status COMPLETED Phase PHASE1
NCT01033227 Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease Status TERMINATED Phase PHASE1/PHASE2
NCT00993044 A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin Status COMPLETED Phase PHASE1
NCT00981370 Clinical Importance of Treating Iron Overload in Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT00939380 Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial Status COMPLETED Phase NA
NCT00870636 Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP) Status NO_LONGER_AVAILABLE Phase N/A
NCT00844051 Study to Evaluate Impact of School-based Influenza Vaccination on School Populations Status COMPLETED Phase NA
NCT00839202 Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay Status COMPLETED Phase NA
NCT00825591 Biological Clock Dysfunction in Optic Nerve Hypoplasia Status COMPLETED Phase EARLY_PHASE1
NCT00812370 The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids Status COMPLETED Phase PHASE1
NCT00743496 A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma Status COMPLETED Phase PHASE1